Respiratory Disorders

Disposable parts were instituted because of previous concerns that the device is difficult to clean and may harbor bacteria.

Treatment with dupilumab led to a significant 30% reduction in moderate or severe acute COPD exacerbations.

Inspire therapy is a fully implanted neurostimulation device that consists of a small generator, a sensing lead, and a stimulation lead.

Pulmonary function tests may be beneficial every six months, may be of use in initiating noninvasive ventilation when indicated

Sudden unexplained infant death rates increased among non-Hispanic Black infants, but not overall

Longer visits were associated with decline in inappropriate antibiotic prescription for upper respiratory tract infection, opioid-benzodiazepine coprescribing

Significant reductions seen in RSV-related infections, RSV-related hospitalizations for three monoclonal antibodies versus placebo

Agency’s Nonprescription Drugs Advisory Committee will meet in April to consider the effectiveness of the oral version of phenylephrine

The FDA panel reviewed data from 5 clinical studies, including the phase 3 AReSVi 006 trial.

Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86 percent

To assess the potential risk, the FDA is working with manufacturers of neonatal incubators and evaluating data from their products.

One in three reach for medication to give their children at temperatures below 100.4, despite knowing that a low-grade fever helps fight infection

The BLA is supported by data from a phase 3 trial which included approximately 7400 pregnant individuals.

High vaccine efficacy seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions

COVID-19 tied to approximately doubled in-hospital mortality rates versus bacterial or other viral pneumonias

Updated review reveals supplementation does not impact rate of exacerbations requiring systemic corticosteroids

The new prefilled, single-use pen is provided as 210mg/1.91mL (110mg/mL) for subcutaneous injection into the thigh or abdomen.

Belimumab is a B-lymphocyte stimulator-specific inhibitor.

Increases seen compared with states where neither recreational nor medical legalization has occurred

Airsupra is a first-in-class, pressurized metered dose inhaler, fixed-dose combination of albuterol and budesonide.